Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

N/ANot Yet RecruitingNCT06742255

Assiut University34 enrolled

Overview

The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain

Study Type

OBSERVATIONAL

Enrollment

Conditions

Stellate Ganglion Facial Palsy Pain Management

Interventions

Stellate Ganglion BlockDRUG

Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * facial nerve palsy patients Exclusion Criteria: 1. light of a recent myocardial infarction. 2. anticoagulant use 3. glucoma 4. lateral nerve palsy 5. emphysema 6. cardiac conduction abnormalities 7. active infection, flu, cold 8. uncontrolled cough 9. Fever 10. Very high blood pressure or if you are on blood thinners. 11. allergic reaction to local anesthetics 12. Primary and secondary coagulopathy.

Outcomes

Primary Outcomes

Primary outcome: Average motor conduction latency in six muscle of the face

Time frame: 6 month

Secondary Outcomes

Improved muscle tone

facial muscles start to regain their strength improvement of muscle tone.

Time frame: 6 months

Central Contacts

Remonda Zaki Abd El Naeem

CONTACT

+201200184996 mondazaki1996@gmai.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.